0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Integration of intratumoral and peritumoral CT radiomic features with machine learning algorithms for predicting induction therapy response in locally advanced non-small cell lung cancer

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objectives

          To extract intratumoral, peritumoral, and integrated intratumoral-peritumoral CT radiomic features, develop multi-source radiomic models using various machine learning algorithms to identify the optimal model, and integrate clinical factors to establish a nomogram for predicting the therapeutic response to induction therapy(IT) in locally advanced non-small cell lung cancer.

          Methods

          This study included 209 patients with locally advanced non-small cell lung cancer (LA-NSCLC) who received IT as the training cohort, and an external validation cohort comprising 50 patients from another center. Radiomic features were extracted from intratumoral, peritumoral, and integrated intratumoral-peritumoral regions by manually delineating the gross tumor volume (GTV) and an additional 3 mm surrounding area. Three machine learning algorithms—Support Vector Machine (SVM), XGBoost, and Gradient Boosting—were employed to construct radiomic models for each region. Model performance was evaluated in the external validation cohort using metrics such as Area Under the Curve (AUC), confusion matrix, accuracy, precision, recall, and F1 score. Finally, a comprehensive nomogram integrating the optimal radiomic model with independent clinical predictors was developed.

          Results

          Through a comparison of optimal machine learning algorithms, INTRAPERI, INTRA, and PERI achieved the best performance with Gradient Boosting, SVM, and XGBoost, respectively. Compared to the INTRA_SVM and PERI_XGBoost INTRA models, the fusion model that integrates INTRA and peritumoral regions within a 3 mm margin around the tumor (INTRAPERI_GradientBoosting) showed better predictive performance in the training set, with AUCs of 93.7%, 82.5%, and 89.4%, respectively. In the clinical model, the PS score was identified as an independent predictive factor. The nomogram combining clinical factors with the INTRAPERI_GradientBoosting score demonstrated clinical predictive value.

          Conclusion

          The INTRAPERI_GradientBoosting model, which integrates intra-tumoral and peritumoral features, performs better than the INTRA intra-tumoral and PERI peritumoral radiomics models in predicting the efficacy of IT therapy in LA-NSCLC. Additionally, the nomogram based on INTRAPERI intra-tumoral and peritumoral features combined with independent clinical predictors has clinical predictive value.

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s12885-025-13804-x.

          Related collections

          Most cited references25

          • Record: found
          • Abstract: found
          • Article: not found

          Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

          In 2015, the second cycle of the CONCORD programme established global surveillance of cancer survival as a metric of the effectiveness of health systems and to inform global policy on cancer control. CONCORD-3 updates the worldwide surveillance of cancer survival to 2014.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            RECIST 1.1-Update and clarification: From the RECIST committee.

            The Response Evaluation Criteria in Solid Tumours (RECIST) were developed and published in 2000, based on the original World Health Organisation guidelines first published in 1981. In 2009, revisions were made (RECIST 1.1) incorporating major changes, including a reduction in the number of lesions to be assessed, a new measurement method to classify lymph nodes as pathologic or normal, the clarification of the requirement to confirm a complete response or partial response and new methodologies for more appropriate measurement of disease progression. The purpose of this paper was to summarise the questions posed and the clarifications provided as an update to the 2009 publication.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Introduction to Radiomics

                Bookmark

                Author and article information

                Contributors
                guozhengjun@hospital.cqmu.edu.cn
                yangzz@cqmu.edu.cn
                2023440076@stu.cqmu.edu.cn
                Journal
                BMC Cancer
                BMC Cancer
                BMC Cancer
                BioMed Central (London )
                1471-2407
                13 March 2025
                13 March 2025
                2025
                : 25
                : 461
                Affiliations
                [1 ]Department of Cancer Center, The Second Affiliated Hospital of Chongqing Medical University, ( https://ror.org/00r67fz39) No. 288 Tianwen Road, Nan’an District, Chongqing, 400010 China
                [2 ]Department of Oncology and Hematology, The First People’s Hospital of Longquanyi District, No. 669, Donglang Road, Chengdu, 610100 China
                [3 ]Chongqing Key Laboratory of Immunotherapy, ( https://ror.org/02d217z27) Chongqing, 400010 China
                Article
                13804
                10.1186/s12885-025-13804-x
                11907900
                40082786
                285f5ca2-7e0e-4ed7-ade4-80d2ebbcdcdb
                © The Author(s) 2025

                Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

                History
                : 22 December 2024
                : 25 February 2025
                Funding
                Funded by: Natural Science Foundation of Chongqing
                Award ID: CSTB2023NSCQ-MSX0059
                Award ID: CSTB2023NSCQ-MSX0059
                Award ID: CSTB2023NSCQ-MSX0059
                Award ID: CSTB2023NSCQ-MSX0059
                Funded by: FundRef https://doi.org/10.13039/501100001809, National Natural Science Foundation of China;
                Award ID: No.82273572
                Award ID: No.82273572
                Award ID: No.82273572
                Award ID: No.82273572
                Funded by: Chengdu Longquanyi district health committee medical topic Program of Chengdu
                Award ID: WJKY2024010
                Award ID: WJKY2024010
                Categories
                Research
                Custom metadata
                © BioMed Central Ltd., part of Springer Nature 2025

                Oncology & Radiotherapy
                radiomics,non-small cell lung cancer (nsclc),locally advanced,induction therapy,machine learning,ct imaging,intra-tumoral features,peritumoral features,predictive model,nomogram

                Comments

                Comment on this article